Neurobehavioural deficits following postnatal iron overload: I spontaneous motor activity.
Fredriksson
A
A
Schröder
N
N
Archer
T
T
D015632:1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine / Q000494:pharmacology; D000818:Animals; D000831:Animals, Newborn; D001479:Basal Ganglia / Q000187:drug effects / Q000378:metabolism; D001921:Brain / Q000378:metabolism; D001923:Brain Chemistry / Q000187:drug effects; D015259:Dopamine Agents / Q000494:pharmacology; D005260:Female; D007501:Iron / Q000378:metabolism; D019190:Iron Overload / Q000378:metabolism / Q000523:psychology*; D007980:Levodopa / Q000494:pharmacology; D008297:Male; D051379:Mice; D008810:Mice, Inbred C57BL; D009043:Motor Activity / Q000187:drug effects*; D010302:Parkinson Disease, Secondary / Q000139:chemically induced / Q000503:physiopathology; D017397:Prefrontal Cortex / Q000187:drug effects / Q000378:metabolism; D011247:Pregnancy; D015430:Weight Gain / Q000187:drug effects
D015259:Dopamine Agents; D007980:Levodopa; D015632:1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; D007501:Iron